Log In
Print
BCIQ
Print
Print this Print this
 

CHF 5074, CHF5074

  Manage Alerts
Collapse Summary General Information
Company Chiesi Farmaceutici S.p.A.
DescriptionSmall molecule microglia modulator
Molecular Target
Mechanism of ActionMicroglia modulator
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

Partner

CereSpir Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today